June 22, 2020 / 1:50 PM / 21 days ago

BRIEF-Esperion Enters Into Amendment No. 1 To License And Collaboration Agreement With Daiichi Sankyo Europe GmbH

June 22 (Reuters) - Esperion Therapeutics Inc:

* ESPERION THERAPEUTICS - ENTERED INTO AMENDMENT NO. 1 TO LICENSE AND COLLABORATION AGREEMENT WITH DAIICHI SANKYO EUROPE GMBH

* ESPERION THERAPEUTICS - DSE WILL NOW PAY CO SECOND $150 MILLION MILESTONE BASED ON COMPLETION OF NUSTENDI MAA TRANSFER, IN AMENDMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below